Biopharma Industry Cheers US, EU's Joint AI Principles
Regulators in the United States and European Union delivered some welcome news to the pharmaceutical industry last week by jointly releasing a set of agreed-upon principles intended to guide the use...To view the full article, register now.
Already a subscriber? Click here to view full article